BONE MARROW OSTEOPONTIN AS A PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Kim, S. [1 ]
Ji, Y. S. [1 ]
Yun, J. [1 ]
Kim, H. J. [1 ,2 ]
Kim, K. H. [3 ]
Kim, H. J. [1 ,2 ]
Lee, S. C. [2 ]
Bae, S. B. [2 ]
Kim, C. K. [1 ]
Lee, N. S. [3 ]
Lee, K. T. [2 ]
Park, S. K. [1 ]
Won, J. H. [3 ]
Hong, D. S. [1 ]
机构：
[1] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Bucheon, South Korea
[2] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Cheonan, South Korea
[3] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Seoul, South Korea
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1828
引用
收藏
页码：723 / 723
页数：1
相关论文
共 50 条
  • [21] DasatinibGelatinous bone marrow transformation and myelodysplastic syndrome: case report
    Reactions Weekly, 2019, 1749 (1) : 163 - 163
  • [22] BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKEMIAS
    DEWITTE, T
    GRATWOHL, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (03) : 361 - 364
  • [23] Bone marrow transplantation for myelodysplastic syndrome - who? when? and which?
    Luger, S
    Sacks, N
    BONE MARROW TRANSPLANTATION, 2002, 30 (04) : 199 - 206
  • [24] Unrelated Donor Bone Marrow Transplantation for Myelodysplastic Syndrome in Children
    Woodard, Paul
    Carpenter, Paul A.
    Davies, Stella M.
    Gross, Thomas G.
    He, Wensheng
    Zhang, Mei-Jie
    Horn, Biljana N.
    Margolis, David A.
    Perentesis, John P.
    Sanders, Jean E.
    Schultz, Kirk R.
    Seber, Adriana
    Woods, William G.
    Eapen, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 723 - 728
  • [25] GELATINOUS TRANSFORMATION OF BONE MARROW: A RARE PRESENTATION OF MYELODYSPLASTIC SYNDROME
    Hussain, S.
    Koshy, N. V.
    Dowden, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (04) : 615 - 616
  • [26] Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications
    Invernizzi, Rosangela
    Travaglino, Erica
    Della Porta, Matteo Giovanni
    Malcovati, Luca
    Galli, Anna
    Bastia, Raffaella
    Ciola, Mariella
    Ambaglio, Ilaria
    Boveri, Emanuela
    Rosti, Vittorio
    Cazzola, Mario
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1711 - 1720
  • [27] BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia
    Vidal, Valerie
    Robert, Guillaume
    Goursaud, Laure
    Durand, Laetitia
    Ginet, Clemence
    Karsenti, Jean Michel
    Luciano, Frederic
    Gastaud, Lauris
    Garnier, Georges
    Braun, Thorsten
    Hirsch, Pierre
    Raffoux, Emmanuel
    Nloga, Anne Marie
    Padua, Rose Ann
    Dombret, Herve
    Rohrlich, Pierre
    Ades, Lionel
    Chomienne, Christine
    Auberger, Patrick
    Fenaux, Pierre
    Cluzeau, Thomas
    ONCOTARGET, 2017, 8 (29) : 47103 - 47109
  • [28] ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME COMPLICATING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BASHIR, S
    COOK, P
    KATZ, M
    MITTELMAN, A
    AHMED, T
    CANCER INVESTIGATION, 1994, 12 (05) : 484 - 487
  • [29] PCNA/Cyclin: A diagnostic and prognostic factor for myelodysplastic syndrome patients
    Bourantas, K
    Ioachim, E
    Demou, A
    Tsiara, S
    Agnantis, NJ
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1996, 15 (02) : 191 - 195
  • [30] Prognostic significance of bone marrow cellularity in myelodysplastic syndromes: a retrospective analysis.
    Morita, Kiyomi
    Ali, Abdullah
    Coutinho, Diego
    Mushtaq, Muhammad Umair
    Raza, Azra
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345